Navigation Links
Bavarian Nordic A/S - Half Year Interim Report 2009
Date:8/28/2009

ry of IMVAMUNE(R) to the US government to be initiated during the period between fourth quarter of 2009 and the end of second quarter 2010.

As the company is awaiting the exact timing of the FDA review and final acceptance the timing of the actual initiation of delivery is at present uncertain. In order to reflect this, the expectations for the financial result for the full year 2009 are at present indicated as a range. The expected revenue of DKK 375 million was based on the delivery of 2 million doses of IMVAMUNE(R) in 2009. Depending on the timing for initiation of delivery, the revenue is now expected to be in the range of DKK 100-300 million, based on a maximum delivery of 1.5 million doses. The result before tax is expected to be a loss between DKK 275-325 million (previously DKK 225 million). The net free liquidity at year-end is expected to be in the range between DKK 175-350 million (previously DKK 400 million). Bavarian Nordic maintains its long-term expectations to the net free liquidity to be around DKK 800 million by year-end 2012.

In order for the company to maintain a solid cash position, the company has implemented a number of operational activities, thus postponing certain costs and investments until deliveries under RFP-3 can begin.

IMVAMUNE(R) - third generation smallpox vaccine candidate

Deliveries under the RFP-3 contract

In order to initiate the delivery of the 20 million doses of IMVAMUNE(R) to the US under the RFP-3 contract, Bavarian Nordic has to fulfil certain requirements set by the U.S. Food and Drug Administration (FDA) to potentially support the use of IMVAMUNE(R) following a declared emergency. These requirements include animal efficacy data, clinical safety data and the demonstration that the manufacturing of IMVAMUNE(R) is in accordance with industry standards associated with a marketed product.

Bavarian Nordic has successfully
'/>"/>

SOURCE Bavarian Nordic A/S
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Bavarian Nordic Receives $50 Million Advance Payment from HHS for Fulfilling Contract Milestones
2. Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process
3. Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 June 2008
4. Bavarian Nordic Receives USD 25 Million Milestone Payment After Submission of Important IMVAMUNE(R) Data to The U.S. Health Authorities
5. Bavarian Nordics Case Against Oxford BioMedica
6. Bavarian Nordic Has Essentially Agreed a Pathway for the Licensure of IMVAMUNE(R) With the FDA After Successful End of Phase II Meeting
7. Bavarian Nordic Publishes its Annual Results 2008
8. Bavarian Nordic Announces its Interim Report for the Period 1 January to 31 March 2009
9. The Court Supports Bavarian Nordics Decision to Start Patent Infringement Case Against Oxford BioMedica
10. Bavarian Nordic in Negotiations With the US Authorities for the Further Development of IMVAMUNE(R)
11. ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... PORTOLA VALLEY, Calif. , July 31, 2014 /PRNewswire/ ... San Francisco Bay Area , has ... the University of Oxford,s commercialisation company. The potent anti-inflammatory ... David Greaves at the University of Oxford,s Sir ... The company, which has raised over $1.5 million ...
(Date:7/31/2014)... Francisco, California (PRWEB) July 31, 2014 ... systems that inform therapeutic decision-making in oncology, today announced ... August 14, 2014 to discuss the Company's financial results ... provide an update about the business in the current ... audio call beginning on Thursday, August 14, 2014, at ...
(Date:7/31/2014)... 2014 Rancho BioSciences , the ... Omicsoft’s Array Suite with tranSMART . Scientists ... to send data in tranSMART to Array Suite for ... of tranSMART including the new 1.2 release. Array ... storage for the analysis of high dimensional quantification data, ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 ... and collaboration company, is proud to announce the ... LMS complements Adobe Connect’s elearning tools to quickly ... delivers content with training tools for desktop and ... with LMS is the perfect online training solution, ...
Breaking Biology Technology:Oxford licenses anti-inflammatory peptides to San Francisco Bay Area start-up 2Oxford licenses anti-inflammatory peptides to San Francisco Bay Area start-up 3CollabRx, Inc. Schedules First Quarter Fiscal Year 2015 Financial Conference Call and Business Update 2Rancho BioSciences, in Partnership with Omicsoft, have Integrated Array Suite with tranSMART 2Rancho BioSciences, in Partnership with Omicsoft, have Integrated Array Suite with tranSMART 3SoundConnect Enhances Portfolio with Adobe Connect Learning Management System (LMS) 2
... 9 Burrill Merchant Banking acted as,exclusive financial ... partnering of bilastine with the Menarini Group (Italy). ... bilastine rights in Europe,and other regions to Menarini ... is a new highly selective H1 antihistamine for ...
... 9 Barr Pharmaceuticals,Inc. (NYSE: BRL ) ... a challenge of the patents listed by Sanofi-Aventis ... Solution), 5mg/mL,Injectable., Barr filed an Abbreviated New ... a generic Eloxatin product with the U.S.,Food & ...
... Quintiles,Transnational Corp. today announced the expansion and consolidation ... (CDS) units,in Beijing to accommodate their growing business ... facility, with more than 17,000,square feet of space, ... Beijing, about,one block from the previous lab site ...
Cached Biology Technology:Burrill Merchant Banking Advises Faes Farma on Bilastine Licensing Agreement 2Barr Confirms Patent Challenge of Eloxatin(R) Injectable, 5mg/mL 2Barr Confirms Patent Challenge of Eloxatin(R) Injectable, 5mg/mL 3Quintiles Central Lab, Clinical Development in China to Expand, Relocate to New Facility 2
(Date:7/31/2014)... , July 31, 2014 NXT-ID, Inc., ... growing m-commerce market, reminds investors and consumers wanting ... wallet, Wocket™, that it will be on-air today, July ... Wocket smart wallet will be featured in a ... television show that airs on the History Channel, ...
(Date:7/30/2014)... The black truffle uses reversible epigenetic processes to regulate ... The ,methylome, - a picture of the genome regulation ... open access journal Genome Biology and illustrates ... elements and ,jumping genes,. The authors say this may ... are controlled. , Black truffles (Tuber melanosporum), also known ...
(Date:7/30/2014)... potential effects of climate change on the world,s ... wrong factors, according to a new paper by ... University of Queensland, and other organizations. The authors ... missing the point when it comes to climate ... change scientists focus on the "direct" threats of ...
Breaking Biology News(10 mins):NXT-ID's Next Generation Biometric Smart Wallet Featured on NewsWatch Consumer Show on the History Channel and FYI Network Today, July 31st 2NXT-ID's Next Generation Biometric Smart Wallet Featured on NewsWatch Consumer Show on the History Channel and FYI Network Today, July 31st 3How black truffles deal with the jumpers in their genome 2Conservation scientists asking wrong questions on climate change impacts on wildlife 2
... health in the past, and are bound to do ... example, led to many illnesses and deaths from breathing ... vying for scarce food, shelter, and work. Future ... ramifications. Following a request from Gov. Christine Gregoire, Washington ...
... colds? How do viruses get into cells? In pursuing this ... since 1997, and his team have pioneered research in this ... the Swiss Nobel Prize in Bern, Switzerland. This award is ... well a confirmation of our long years of work, and ...
... #1 FOR IMMEDIATE RELEASE Spinning a new role ... and DVDs and the hardware used to play these popular ... a new generation of portable, inexpensive instruments for home health ... in the Oct. 15 issue of ACS Analytical Chemistry, a ...
Cached Biology News:University and state agencies to forecast local health effects of climate change 2University and state agencies to forecast local health effects of climate change 3University and state agencies to forecast local health effects of climate change 4ETH Zurich professor Ari Helenius awarded Benoist Prize 2American Chemical Society's Weekly PressPac -- Sept. 19, 2007 2American Chemical Society's Weekly PressPac -- Sept. 19, 2007 3American Chemical Society's Weekly PressPac -- Sept. 19, 2007 4American Chemical Society's Weekly PressPac -- Sept. 19, 2007 5American Chemical Society's Weekly PressPac -- Sept. 19, 2007 6American Chemical Society's Weekly PressPac -- Sept. 19, 2007 7American Chemical Society's Weekly PressPac -- Sept. 19, 2007 8
Human/Mouse G9a/EHMT2 MAb (Clone A8620A) Keywords: Eu-HMTase2...
Human M-CSF...
Human Serpin B5/Maspin Affinity Purified Polyclonal Ab...
... (1995) This book contains up ... current issues relating to the aetiology and ... have been made recently which greatly improve ... molecular neuropathology through clinical and diagnostic aspects, ...
Biology Products: